Investing For The Diabetes Epidemic (at Investopedia)

Medtronic: Poised for Superior Results (at Seeking Alpha)

FDA Positive on Medtronic's Device (Zacks)
Medtronic Inc. received positive recommendation from the U.S. Food and Drug Administration's Orthopaedic and Rehabilitation Devices panel, for its Spinal Device, Amplify recombinant human bone morphogenetic protein Matrix.

Medtronic Launches Novel Clinical Trial Evaluating Spinal Cord Stimulation Therapy for Heart Failure (Business Wire)
MINNEAPOLIS----Medtronic, Inc. today announced the global launch of the Defeat-HF clinical trial. It is the industry?s first prospective, randomized study evaluating the clinical feasibility of spinal cord stimulation , or neurostimulation, to improve clinical signs and symptoms of heart failure.

FDA panel recommends Medtronic spinal implant (AP)
A Food and Drug Administration advisory panel has recommended clearance for Medtronic's spinal implant Amplify. The FDA's Orthopedic and Rehabilitation Devices Panel voted 6-to-5 in favor of the device, which stimulates bone growth in spinal surgery patients.

Vegas Condos-Time to Buy? (at CNBC)
Las Vegas home sales surged in June, thanks in part to some movement in the hard hit high-rise condo market on the Strip. The Las Vegas Review Journal says sales doubled from a year ago, "driven by 79 high-rise condominium sales."